Literature DB >> 12823199

Clinical findings and risk factors for Candida esophagitis in outpatients.

J A Underwood1, J W Williams, R F Keate.   

Abstract

We retrospectively reviewed 18 patients with endoscopically discovered Candida esophagitis to more fully characterize this entity and identify predisposing conditions. Candida esophagitis was defined by the presence of fungal mycelia on brush cytology. Only two patients had an associated malignancy. Other possible predisposing risk factors were acid suppressive therapy (14 patients), prior gastric surgery (five), mucosal barrier injury (four), inhaled steroid use (four), oral steroid use (three), esophageal motility disorders (three), rheumatologic disorders (three), prior antibiotic use (two) and diabetes mellitus (two). The majority of patients had more than one proposed risk factor. Ten (56%) were treated with antifungal therapy. Thus, Candida esophagitis was infrequently seen in patients with associated malignancy. Prospective evaluation of predisposing conditions and treatment is recommended.

Entities:  

Mesh:

Year:  2003        PMID: 12823199     DOI: 10.1046/j.1442-2050.2003.00305.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  15 in total

1.  Acid suppression therapy as a risk factor for Candida esophagitis.

Authors:  Kyung-Yup Kim; Jae Young Jang; Jung-Wook Kim; Jae-Jun Shim; Chang Kyun Lee; Seok Ho Dong; Hyo Jong Kim; Byung-Ho Kim; Young Woon Chang
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

2.  Trichosporon inkin Esophagitis: An Uncommon Disease in a Patient with Pulmonary Cancer.

Authors:  Danielle Patrícia Cerqueira Macêdo; Neiva Tinti de Oliveira; Vanessa Karina Alves da Silva; Aline Mary de Almeida Farias; Reginaldo Gonçalves de Lima Neto; Ana Botler Wilheim; Patrícia Cariolano de Oliveira; Nadyr Pedi; Suanni Lemos de Andrade; Rejane Pereira Neves
Journal:  Mycopathologia       Date:  2010-09-23       Impact factor: 2.574

3.  Candida esophagitis complicated by an esophago-airway fistula: report of a case.

Authors:  Ryu Kanzaki; Masahiko Yano; Ko Takachi; Shingo Ishiguro; Masaaki Motoori; Kentaro Kishi; Isao Miyashiro; Osamu Ishikawa; Shingi Imaoka
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

4.  Esophageal candidiasis in an immunocompetent girl.

Authors:  Mohammed Yahya Hasosah; Mahmmod Showail; Ashraf Al-Sahafi; Mohammed Satti; Kevan Jacobson
Journal:  World J Pediatr       Date:  2009-07-09       Impact factor: 2.764

5.  Evaluation and Management of Infectious Esophagitis in Immunocompromised and Immunocompetent Individuals.

Authors:  Nitin K Ahuja; John O Clarke
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03

6.  Laparoscopic Sleeve Gastrectomy Esophageal Candidiasis an Exceptional Complication of Laparoscopic Sleeve Gastrectomy: First Case Report.

Authors:  Ahmed Saidani; Hichem Rakkeh; Anis Belhaj; Mahdi Debaibi; Faouzi Chebbi
Journal:  Obes Surg       Date:  2021-04-18       Impact factor: 4.129

7.  Prevalence, Predictors, and Outcomes of Esophageal Candidiasis in Cirrhosis: An Observational Study With Systematic Review and Meta-Analysis (CANDID-VIEW).

Authors:  Nipun Verma; Saurabh Mishra; Shreya Singh; Arka De; Madhumita Premkumar; Sunil Taneja; Ajay Duseja; Virendra Singh
Journal:  J Clin Exp Hepatol       Date:  2021-03-21

8.  Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients.

Authors:  Yuta Takahashi; Naoyoshi Nagata; Takuro Shimbo; Takeshi Nishijima; Koji Watanabe; Tomonori Aoki; Katsunori Sekine; Hidetaka Okubo; Kazuhiro Watanabe; Toshiyuki Sakurai; Chizu Yokoi; Masao Kobayakawa; Hirohisa Yazaki; Katsuji Teruya; Hiroyuki Gatanaga; Yoshimi Kikuchi; Sohtaro Mine; Toru Igari; Yuko Takahashi; Akio Mimori; Shinichi Oka; Junichi Akiyama; Naomi Uemura
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

9.  Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report.

Authors:  Kuo-Hsin Chen; Meng-Tzu Weng; Yueh-Hung Chou; Yueh-Feng Lu; Chen-Hsi Hsieh
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

10.  Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea.

Authors:  Jae Hyeuk Choi; Chang Geun Lee; Yun Jeong Lim; Hyoun Woo Kang; Chi Yeon Lim; Jong-Sun Choi
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.